Avita Medical (RCEL) Competitors $4.88 +0.13 (+2.74%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$4.88 0.00 (0.00%) As of 08/22/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RCEL vs. BVS, ZIMV, AVNS, SMLR, KIDS, CBLL, TMCI, DCTH, BFLY, and RXSTShould you be buying Avita Medical stock or one of its competitors? The main competitors of Avita Medical include Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), Semler Scientific (SMLR), OrthoPediatrics (KIDS), CeriBell (CBLL), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Butterfly Network (BFLY), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Avita Medical vs. Its Competitors Bioventus ZimVie AVANOS MEDICAL Semler Scientific OrthoPediatrics CeriBell Treace Medical Concepts Delcath Systems Butterfly Network RxSight Avita Medical (NASDAQ:RCEL) and Bioventus (NYSE:BVS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends. Does the media favor RCEL or BVS? In the previous week, Avita Medical had 14 more articles in the media than Bioventus. MarketBeat recorded 14 mentions for Avita Medical and 0 mentions for Bioventus. Bioventus' average media sentiment score of 0.00 beat Avita Medical's score of -0.13 indicating that Bioventus is being referred to more favorably in the news media. Company Overall Sentiment Avita Medical Neutral Bioventus Neutral Do insiders & institutionals have more ownership in RCEL or BVS? 27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 62.9% of Bioventus shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by company insiders. Comparatively, 33.0% of Bioventus shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, RCEL or BVS? Avita Medical has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Which has higher valuation and earnings, RCEL or BVS? Avita Medical has higher earnings, but lower revenue than Bioventus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvita Medical$64.25M2.02-$61.85M-$1.97-2.48Bioventus$564.14M1.12-$156.23MN/AN/A Do analysts recommend RCEL or BVS? Avita Medical currently has a consensus price target of $12.40, indicating a potential upside of 154.10%. Bioventus has a consensus price target of $13.75, indicating a potential upside of 79.97%. Given Avita Medical's higher probable upside, equities analysts plainly believe Avita Medical is more favorable than Bioventus.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avita Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40Bioventus 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is RCEL or BVS more profitable? Bioventus has a net margin of -7.11% compared to Avita Medical's net margin of -68.87%. Bioventus' return on equity of 15.61% beat Avita Medical's return on equity.Company Net Margins Return on Equity Return on Assets Avita Medical-68.87% -632.62% -71.52% Bioventus -7.11%15.61%4.01% SummaryBioventus beats Avita Medical on 8 of the 14 factors compared between the two stocks. Get Avita Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCEL vs. The Competition Export to ExcelMetricAvita MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$126.44M$2.57B$5.76B$9.58BDividend YieldN/A1.67%4.41%4.10%P/E Ratio-2.4822.6131.1026.04Price / Sales2.02554.26433.45102.77Price / CashN/A180.4637.7358.48Price / Book-10.175.939.536.61Net Income-$61.85M$31.83M$3.26B$265.56M7 Day Performance-13.32%1.89%2.10%1.97%1 Month Performance-22.04%1.33%2.81%-0.36%1 Year Performance-47.75%8.84%30.56%19.03% Avita Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCELAvita Medical1.4327 of 5 stars$4.88+2.7%$12.40+154.1%-44.4%$126.44M$64.25M-2.48130News CoverageBVSBioventusN/A$7.18-2.6%$13.75+91.5%-22.7%$593.64M$564.14M-11.771,200ZIMVZimVie0.7047 of 5 stars$18.95+0.5%$17.75-6.3%+11.2%$531.59M$449.75M-27.071,770Positive NewsShort Interest ↑AVNSAVANOS MEDICAL3.2892 of 5 stars$11.24+0.4%N/A-49.6%$519.71M$687.80M-1.122,227Short Interest ↑SMLRSemler Scientific3.4863 of 5 stars$33.76-0.2%$81.75+142.2%+11.0%$500.99M$56.29M13.89120Gap UpKIDSOrthoPediatrics3.9369 of 5 stars$19.20+0.1%$34.14+77.8%-32.9%$481.16M$204.73M-10.73200CBLLCeriBell2.3431 of 5 stars$12.18-1.1%$32.14+163.9%N/A$451.33M$65.44M-4.07N/ATMCITreace Medical Concepts2.6439 of 5 stars$7.04+2.2%$9.83+39.7%+24.2%$435.26M$209.36M-8.91250DCTHDelcath Systems2.6322 of 5 stars$10.65+2.8%$24.50+130.0%+41.3%$362.41M$37.21M213.0060Short Interest ↑BFLYButterfly Network2.9845 of 5 stars$1.44+0.7%$3.00+108.3%+68.9%$359.99M$82.06M-5.14460RXSTRxSight1.0116 of 5 stars$8.49+0.7%$10.00+17.8%-82.9%$344.92M$139.93M-10.61220Trending NewsShort Interest ↑ Related Companies and Tools Related Companies Bioventus Alternatives ZimVie Alternatives AVANOS MEDICAL Alternatives Semler Scientific Alternatives OrthoPediatrics Alternatives CeriBell Alternatives Treace Medical Concepts Alternatives Delcath Systems Alternatives Butterfly Network Alternatives RxSight Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RCEL) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avita Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avita Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access